Select Language: EN
help/
support
your account
0
 
0
Welcome to Swanson Europe! We are excited to serve both our new and loyal customers from the UK and all across the EU.
All orders are processed and shipped within 24 hours and delivered within 2 business days of shipment by DHL express.
All Orders Are Shipped From European Union | Extra Charges DO NOT Apply | Orders Are Customs Free | Direct Delivery To Your Door

Web Specials


Categories

Quick Links

About Us

Timed-Release Horse Chestnut 22% Aescin

Timed-Release Horse Chestnut 22% Aescin

Rating: 10 Rating: 5.0000
1 Reviews

Code: SWH041

Type200 mg 120 Tabs
Description:

• A terrific vascular tonic
• Excellent herb for promoting vascular tone, especially in the legs and extremities
• 200 mg of horse chestnut standardized to 22% aescin

Add to wishlist Send to friend
* Shipped From European Union
  • Detailed Description

Put the pep back in your step with the herbal vascular support of Swanson Horse Chestnut! The legs and lower extremities are often indicators of circulatory health. That's where horse chestnut comes in. It features a unique natural compound known as aescin, which helps maintain blood vessel integrity to promote healthy circulation to the legs and feet and throughout the body. Our Horse Chestnut delivers a powerful standardized extract (22% aescin content) in special timed-release tablets that allow maximum potency with no stomach upset.

Supplement Facts

Serving Size 1 Timed-Release Tablet

  Amount Per Serving % Daily Value
Horse Chestnut Standardized Extract (22% aescin) (seeds) 200 mg *

*Daily Value not established.

Other ingredients: Calcium carbonate, stearic acid, magnesium stearate, ethylcellulose coated.

Suggested use: As a dietary supplement, take one timed-release tablet two to three times per day with a full glass of water. Timed-release gradually over 6-8 hours.
Size: 200 mg 120 Tabs


LEAVE A COMMENT:

Your email address will not be published. Required fields are marked *




Gregory

  
   18 Feb 2022

5

Nice Product!

+1 0

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.   I agree